Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Determinants of hormone therapy uptake and decision-making after bilateral oophorectomy (BO): A narrative review.

Siyam T, Carbon J, Ross S, Yuksel N.

Maturitas. 2019 Feb;120:68-76. doi: 10.1016/j.maturitas.2018.11.005. Epub 2018 Nov 12. Review.

PMID:
30583767
2.

Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma.

Aguilera KY, Rivera LB, Hur H, Carbon JG, Toombs JE, Goldstein CD, Dellinger MT, Castrillon DH, Brekken RA.

Cancer Res. 2014 Feb 15;74(4):1032-44. doi: 10.1158/0008-5472.CAN-13-2800. Epub 2013 Dec 17.

3.

High heregulin expression is associated with activated HER3 and may define an actionable biomarker in patients with squamous cell carcinomas of the head and neck.

Shames DS, Carbon J, Walter K, Jubb AM, Kozlowski C, Januario T, Do A, Fu L, Xiao Y, Raja R, Jiang B, Malekafzali A, Stern H, Settleman J, Wilson TR, Hampton GM, Yauch RL, Pirzkall A, Amler LC.

PLoS One. 2013;8(2):e56765. doi: 10.1371/journal.pone.0056765. Epub 2013 Feb 28. Erratum in: PLoS One. 2013;8(6). doi:10.1371/annotation/63f57c72-c869-4ef5-94d1-3cbd6c2e3678. AnDo [corrected to Do, An].

4.

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

Kirane A, Toombs JE, Ostapoff K, Carbon JG, Zaknoen S, Braunfeld J, Schwarz RE, Burrows FJ, Brekken RA.

Clin Cancer Res. 2012 Sep 15;18(18):5031-42. doi: 10.1158/1078-0432.CCR-12-0453. Epub 2012 Jul 24.

5.

Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.

Arnold SA, Rivera LB, Carbon JG, Toombs JE, Chang CL, Bradshaw AD, Brekken RA.

PLoS One. 2012;7(2):e31384. doi: 10.1371/journal.pone.0031384. Epub 2012 Feb 14.

6.

DNA methylation regulates phenotype-dependent transcriptional activity in Candida albicans.

Mishra PK, Baum M, Carbon J.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11965-70. doi: 10.1073/pnas.1109631108. Epub 2011 Jul 5.

7.

r84, a novel therapeutic antibody against mouse and human VEGF with potent anti-tumor activity and limited toxicity induction.

Sullivan LA, Carbon JG, Roland CL, Toombs JE, Nyquist-Andersen M, Kavlie A, Schlunegger K, Richardson JA, Brekken RA.

PLoS One. 2010 Aug 6;5(8):e12031. doi: 10.1371/journal.pone.0012031.

8.

Tumor-derived intercellular adhesion molecule-1 mediates tumor-associated leukocyte infiltration in orthotopic pancreatic xenografts.

Roland CL, Dineen SP, Toombs JE, Carbon JG, Smith CW, Brekken RA, Barnett CC Jr.

Exp Biol Med (Maywood). 2010 Feb;235(2):263-70. doi: 10.1258/ebm.2009.009215.

PMID:
20404043
9.

Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

Dineen SP, Roland CL, Greer R, Carbon JG, Toombs JE, Gupta P, Bardeesy N, Sun H, Williams N, Minna JD, Brekken RA.

Cancer Res. 2010 Apr 1;70(7):2852-61. doi: 10.1158/0008-5472.CAN-09-3892. Epub 2010 Mar 23.

10.

Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.

Arnold SA, Rivera LB, Miller AF, Carbon JG, Dineen SP, Xie Y, Castrillon DH, Sage EH, Puolakkainen P, Bradshaw AD, Brekken RA.

Dis Model Mech. 2010 Jan-Feb;3(1-2):57-72. doi: 10.1242/dmm.003228. Epub 2009 Dec 9.

11.

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.

Dineen SP, Sullivan LA, Beck AW, Miller AF, Carbon JG, Mamluk R, Wong H, Brekken RA.

BMC Cancer. 2008 Nov 27;8:352. doi: 10.1186/1471-2407-8-352.

12.

Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity.

Bull Phelps SL, Carbon J, Miller A, Castro-Rivera E, Arnold S, Brekken RA, Lea JS.

Am J Obstet Gynecol. 2009 Feb;200(2):180.e1-7. doi: 10.1016/j.ajog.2008.08.047. Epub 2008 Nov 6.

13.

Centromere size and position in Candida albicans are evolutionarily conserved independent of DNA sequence heterogeneity.

Mishra PK, Baum M, Carbon J.

Mol Genet Genomics. 2007 Oct;278(4):455-65. Epub 2007 Jun 23.

PMID:
17588175
14.

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.

Korpanty G, Carbon JG, Grayburn PA, Fleming JB, Brekken RA.

Clin Cancer Res. 2007 Jan 1;13(1):323-30.

15.

Formation of functional centromeric chromatin is specified epigenetically in Candida albicans.

Baum M, Sanyal K, Mishra PK, Thaler N, Carbon J.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14877-82. Epub 2006 Sep 26.

16.

Establishing a case for cause and effect.

Carbon JR.

J Am Osteopath Assoc. 2006 Aug;106(8):443-4. No abstract available.

PMID:
16943512
17.

Manual therapies.

Carbon JR.

J Am Osteopath Assoc. 2006 May;106(5):304-5. No abstract available.

PMID:
16717376
18.

Inner kinetochore of the pathogenic yeast Candida glabrata.

Stoyan T, Carbon J.

Eukaryot Cell. 2004 Oct;3(5):1154-63.

19.

Centromeric DNA sequences in the pathogenic yeast Candida albicans are all different and unique.

Sanyal K, Baum M, Carbon J.

Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11374-9. Epub 2004 Jul 22.

20.

Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins.

Brekken RA, Sullivan MM, Workman G, Bradshaw AD, Carbon J, Siadak A, Murri C, Framson PE, Sage EH.

J Histochem Cytochem. 2004 Jun;52(6):735-48.

PMID:
15150282
21.

Functional analysis of the matricellular protein SPARC with novel monoclonal antibodies.

Sweetwyne MT, Brekken RA, Workman G, Bradshaw AD, Carbon J, Siadak AW, Murri C, Sage EH.

J Histochem Cytochem. 2004 Jun;52(6):723-33.

PMID:
15150281
22.

SPARC regulates cell cycle progression in mesangial cells via its inhibition of IGF-dependent signaling.

Francki A, Motamed K, McClure TD, Kaya M, Murri C, Blake DJ, Carbon JG, Sage EH.

J Cell Biochem. 2003 Mar 1;88(4):802-11.

PMID:
12577314
23.
24.

Increased fibrovascular invasion of subcutaneous polyvinyl alcohol sponges in SPARC-null mice.

Bradshaw AD, Reed MJ, Carbon JG, Pinney E, Brekken RA, Sage EH.

Wound Repair Regen. 2001 Nov-Dec;9(6):522-30.

PMID:
11896995
25.
26.
27.

Point mutations in yeast CBF5 can abolish in vivo pseudouridylation of rRNA.

Zebarjadian Y, King T, Fournier MJ, Clarke L, Carbon J.

Mol Cell Biol. 1999 Nov;19(11):7461-72.

28.

Slk19p is a centromere protein that functions to stabilize mitotic spindles.

Zeng X, Kahana JA, Silver PA, Morphew MK, McIntosh JR, Fitch IT, Carbon J, Saunders WS.

J Cell Biol. 1999 Jul 26;146(2):415-25.

29.

Probing the Saccharomyces cerevisiae centromeric DNA (CEN DNA)-binding factor 3 (CBF3) kinetochore complex by using atomic force microscopy.

Pietrasanta LI, Thrower D, Hsieh W, Rao S, Stemmann O, Lechner J, Carbon J, Hansma H.

Proc Natl Acad Sci U S A. 1999 Mar 30;96(7):3757-62.

30.

The Nop60B gene of Drosophila encodes an essential nucleolar protein that functions in yeast.

Phillips B, Billin AN, Cadwell C, Buchholz R, Erickson C, Merriam JR, Carbon J, Poole SJ.

Mol Gen Genet. 1998 Oct;260(1):20-9.

PMID:
9829824
31.
32.
33.

A centromere DNA-binding protein from fission yeast affects chromosome segregation and has homology to human CENP-B.

Halverson D, Baum M, Stryker J, Carbon J, Clarke L.

J Cell Biol. 1997 Feb 10;136(3):487-500.

35.

Overexpression of the yeast MCK1 protein kinase suppresses conditional mutations in centromere-binding protein genes CBF2 and CBF5.

Jiang W, Lim MY, Yoon HJ, Thorner J, Martin GS, Carbon J.

Mol Gen Genet. 1995 Feb 6;246(3):360-6.

PMID:
7854321
37.

Cloning and characterization of centromeric DNA from Neurospora crassa.

Centola M, Carbon J.

Mol Cell Biol. 1994 Feb;14(2):1510-9.

38.

An essential yeast protein, CBF5p, binds in vitro to centromeres and microtubules.

Jiang W, Middleton K, Yoon HJ, Fouquet C, Carbon J.

Mol Cell Biol. 1993 Aug;13(8):4884-93.

39.
40.

Molecular analysis of the budding yeast centromere/kinetochore.

Jiang W, Carbon J.

Cold Spring Harb Symp Quant Biol. 1993;58:669-76. No abstract available.

PMID:
7956083
41.

Microtubule-motor activity of a yeast centromere-binding protein complex.

Hyman AA, Middleton K, Centola M, Mitchison TJ, Carbon J.

Nature. 1992 Oct 8;359(6395):533-6.

PMID:
1406970
43.

A colony bank containing synthetic Col El hybrid plasmids representative of the entire E. coli genome. 1976.

Clarke L, Carbon J.

Biotechnology. 1992;24:179-87. No abstract available.

PMID:
1422012
45.
46.

Clustered tRNA genes in Schizosaccharomyces pombe centromeric DNA sequence repeats.

Kuhn RM, Clarke L, Carbon J.

Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1306-10.

47.

Centromere structure and function in budding and fission yeasts.

Carbon J, Clarke L.

New Biol. 1990 Jan;2(1):10-9. Review. Erratum in: New Biol 1990 Mar;2(3):preceding 207.

PMID:
2078550
48.

Electrophoretic karyotype of Aspergillus nidulans.

Brody H, Carbon J.

Proc Natl Acad Sci U S A. 1989 Aug;86(16):6260-3.

49.

Construction of functional artificial minichromosomes in the fission yeast Schizosaccharomyces pombe.

Hahnenberger KM, Baum MP, Polizzi CM, Carbon J, Clarke L.

Proc Natl Acad Sci U S A. 1989 Jan;86(2):577-81.

50.

Clinical research preparation for chiropractors: implementing a scientist-practitioner model.

Carbon J.

J Manipulative Physiol Ther. 1988 Jun;11(3):231-2. No abstract available.

PMID:
3392482

Supplemental Content

Loading ...
Support Center